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Abstract Trypsin and chymotrypsin have speciIicity pockets of 
essentially the same geometry, yet trypsin is specific for basic 
while chymotrypsin for bulky hydrophobic residues at the Pl site 
of the substrate. A model by Steitz, Henderson and Blow sug- 
gested the presence of a negative charge at site 189 as the major 
specificity determinant: Asp189 results in tryptic, while the lack 
of it chymotryptic specificity. However, recent mutagenesis stud- 
ies have shown that a successful conversion of the specificity of 
trypsin to that of chymotrypsin requires the substitution of amino 
acids at sites 138, 172 and at thirteen other positions in two 
surface loops, that do not directly contact the substrate. For 
further testing the signilicance of these sites in substrate discrim- 
ination in trypsin and chymotrypsin, we tried to change the chy- 
motrypsin specificity to trypsin-like specificity by introducing 
reverse substitutions in rat chymotrypsin. We report here that the 
specificity conversion is poor: the Serl89Asp mutation reduced 
the activity but the specificity remained chymotrypsin-like; on 
further substitutions the activity decreased further on both tryptic 
and chymotryptic substrates and the specificity was lost or be- 
came slightly trypsin-like. Our results indicate that in addition to 
structural elements already studied, further (chymotrypsin) spe- 
cific sites have to be mutated to accomplish a chymotryp- 
sin + trypsin specificity conversion. 
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1. Introduction 
The great achievement of enzymes is the enormous accelera- 
tion of chemical reactions accompanied by a strict discrimina- 
tion between substrates. There is a - lo4 fold difference be- 
tween trypsin and chymotrypsin activities if they are compared 
on polypeptide amide substrates with Phe and Lys side chains 
at the Pl position’ despite the fact that the main chain atom 
positions are almost identical in the two enzymes in the Sl 
specificity site. (They are superimposable with a root-mean 
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‘Pl denotes the amino acid residue of the substrate that interacts with 
the Sl site of the enzyme. The scissile bond is between sites Pl and 
Pl’ [I]. 
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square deviation of less than 0.6 8, [2]). Since the Sl site is the 
primary specificity determinant, the specificity difference has 
been ascribed mainly to the presence of the negative charge of 
the AspIs carboxylate in trypsin (matching the positive charge 
of the Pl side chain in the substrate) and its absence in chymo- 
trypsin [3]. Two other differences were also thought to have 
some role. One of these is the position of Ser190 side chain. It 
is rotated out of the pocket in chymotrypsin while in trypsin 
it is in the pocket and can form a hydrogen bond with a Pl- 
arginine side chain [47]. The other difference is at site 192: 
methionine in chymotrypsin can provide a slightly more hydro- 
phobic environment for the substrate than glutamine, the 
amino acid at this position in trypsin [8]. 
Suprisingly enough, the corresponding mutations in trypsin 
did not transform the specificity: although the trypsin activity 
measured on polypeptide amide substrates were already com- 
pletely gone on an Aspl89Ser substitution [9], no significant 
chymotrypsin-like activity was observed. Moreover, the tryptic 
activity of this mutant returned when non-covalently bound 
acetate ion was present in the pocket [lo]. Further substitutions 
at sites 138 and 192 did not significantly change the chymotryp- 
tic activity of the Ser189 trypsin [2]. Partial replacement in a 
surface loop (later referred to as 100~2, sites 2 17-224) raised the 
chymotrypsin-like activity 240 fold (Depending on the Pl side 
chain) as compared to Ser 189 trypsin [ 121. Further substitutions 
to modify the amino acid sequence to a chymotrypsin like one 
in loop2 and in an other surface loop (100~1, sites 184a through 
195), along with a Ile13’Thr mutation, incrased the activity to 
one percent of wild type chymotrypsin (Tr -+ Ch[Sl + 
Ll + L2] trypsin mutant in ref. [2]). A Tyrl72Trp substitution 
in the latter mutant brought the activity of the mutant enzyme 
into the range of wild-type chymotrypsin [13,14]. From these 
findings it was concluded that sites 138, 172, 184a-189, 192, 
217-224 have a significant role in determining the substrate 
specificity of trypsin [l 11. 
It appeared to be likely that the sites listed above have a 
general role in determining both chymotrypsin and trypsin-like 
specificities. If this were the case, the reverse amino acid substi- 
tutions in chymotrypsin would convert its specificity to that of 
trypsin, similarly to the specificity conversion in trypsin upon 
substitutions at the same sites. We examined this possibility by 
generating and kinetically characterizing a series of rat chymo- 
trypsin mutants. 
2. Materials and methods 
2.1. Materials 
Highly purified enterokinase was the product of Biozyme (EK-3). 
TSK-Toyopearl SP-650M cation exchanger was obtained from Su- 
pelco. SBTI-Sepharose, MUTMAC, MUGB, AMC and 7-methylum- 
belliferon were from Sigma Chemical Co. The tetrapeptide substrates 
with AMC fluorogenic leaving group were prepared as described [9]. 
All rights reserved. 
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2.2. Cloning of rat chymotrypsinogen 
A lambda gtll cDNA library of the rat cell line, AR425 (from Chris 
Nelson) was amplified by polymerase chain reaction using two oligonu- 
cleotides corresponding to the 5’ and 3’ ends of the chymotrypsinogen 
coding region. At the same time the oligonucleotides (5’~GCCACCC- 
AAGCTTGTGGAGTCCCT-3’ and 5’-GCGAGCTCAGGTGTCTT- 
CCAAGAT-3’) added a Hind111 site to the 5’ end and a Sac1 site to the 
3’ end. 
2.3. Mutagenesis 
Asp189 chymotrypsin and its mutant derivatives, mutant 12, 13, 19. 
21 and 43 were constructed according to Kunkel [15] using the follow- 
ing oligonucleotides: 5’-GCTAGCGGCGTCGATTCCTGCATG- 
GGT-3’ (to construct the Asp189 chymotrypsin from the wild-type 
enzyme); S-ACTGTGTGCGCAATCACTGGCTGGGGC-3’ (to in- 
troduce a Thrl38Ile mutation into the Asp189 chymotrypsin); 5’-GT- 
GATGACCTGCGCAGGCTTCCTCGAGGGCGGCAAGGATTC- 
CTGCCAGGGTGACTCCGGTC-3’ (to introduce mutations in loop1 
of Asp189 chymotrypsin); 5’-GTGTCCTGGGGCTATGGCTGTGC- 
CCTTCCGGACAATCCTGCTGTGTATCC-3’ and 5’-TGTGCCCT- 
TCCGAGTACTCCTGCTGTGTATTCACGCGTCACAGCC-3’ (to 
introduce substitutions in loop2 of Asp189 chymotrypsin); 5’-CAGC- 
AGGCCGCGGCGCCCATCGTCTCCGAGGCTGACTGCAAGA- 
AGTCGTACGGTTCCAAGATCACCGATGTGATGATCTGCGC- 
AGGC-3’ (to introduce mutations Leul60Ala and Trpl72Phe). The 
mutations in chymotrypsin at site 138 and in the two loops were intro- 
duced in a single mutagenesis step using three oligos simultaneously on 
the same template. Mutants 21 and 49 were generated from the combi- 
nation of the other chymotrypsin mutants. 
Throughout this study we expressed that forms of wild-type and 
mutant chymotrypsinogens in which the chymotrypsin propeptide was 
substituted for trypsin propeptide and site Cys122 was mutated to Ser 
for two reasons: (i) the chimeras could be activated with enterokinase, 
which minimized the contamination of the enzyme preparations with 
trypsin (in this way the accurate determination of very low tryptic 
activities of the wild-type and mutant enzymes became possible); (ii) the 
chimeric form of zymogen chymotrypsin proved to be much more 
stable than the natural wild-type (chymotrypsin propeptide containing) 
form, resulting in a higher yield during enzyme preparation. (For con- 
struction characterization of these chimeras see the accompanying 
paper.) The mutations were verified by DNA sequencing. 
2.4. Expression 
The mutant and wild-type chymotrypsinogens (in propeptide chi- 
mera form ~ see above) and wild-type trypsinogen were expressed in 
yeast by fusing the enzyme coding sequences to an a-factor leader 
peptide containing sequence as described for carboxypeptidase [16]. 
The culture medium was separated by centrifugation and the proteins 
were isolated on TSK-Toyopearl SP-650 cation exchanger [17]. The 
zymogens were activated by highly purified enterokinase at a 100: 1 
zymogen/enterokinase ratio, then the active forms were purified by 
affinity chromatography on SBTI-Sepharose column. The mutant en- 
zymes were always purified on unused affinity gels. The purity of the 
preparates was analyzed by SDS polyacrylamide gel electrophoresis. 
The enzyme concentration was determined by BioRad protein assay for 
the mutants of low activity and by active site titration with MUTMAC 
and MUGB [18] for the wild-type enzymes. 
2.5. Enzyme assays 
Amide hydrolysis was measured on Succinyl-AlaAlaProXaa-AMC 
substrates (Xaa was Phe, Tyr, Leu, Trp, Lys and Arg) in a 50 mM 
HEPES, 10 mM CaCl,, 0.1 M NaCl (pH 8.0) buffer at 37°C using a 
Perkin Elmer LS5 spectrofluorimeter. The data were analyzed with 
KinetAsyst software. 
2.6. Computer graphics 
The structure of several bovine trypsin and chymotrypsin molecules 
were compared on the models deposited in the Brookhaven Protein 
Data Bank with the MidasPlus software from the Cornouter Graohics 
Laboratory of University of California, San Francis& For studying 
the differences in the atom positions the models were aligned at the 
cl-carbon atoms of the residues 44, 140, 160, and 200. Located in very 
rigid p-sheet segments both the residue types and their main chain 
conformations are conserved at these sites in trypsins and chymotr 
sins. The r.m.s. error of the alignments ranged from 0.07 to 0.22 K 
p- 
3. Results 
3.1. Description of the mutants 
First the Asp189 chymotrypsin mutant was constructed and 
then other mutants as derivatives, with further substitutions in 
various combinations at sites 138, 160, 172 and at a number of 
sites in loop1 and loop2 (see Fig. 1). Mutants 12 and 13 were 
designed to be the chymotrypsin counterparts of the 
Tr + Ch[Sl + Ll + L2] trypsin mutant 121. The difference be- 
tween mutants 12 and 13, is that mutant 12 does have the 
llel38Thr replacement. Mutant 43 is like mutant 13, but it 
contains a Leul60Ala and a Trpl72Tyr substitutions as well. 
Apart from the mutation at site 160, this mutant is the chymo- 
trypsin counterpart of the Tr + Ch[Sl + Ll + L2 + Yl72W] 
trypsin mutant [13,14]. The Leul60Ala substitution was intro- 
duced to stabilize the environment of Ile138 and Ile16 (Leu 
vs. Ala is a conservative difference at site 160 between mamma- 
lian chymotrypsins and trypsins). Variants of mutants 12, 
13 and 43 were also made in which the amino acids at sites 223 
and 224 in loop2 were not replaced (mutants 19, 21 and 49 ~ 
Fig. 1). 
3.2. Kinetic characterization of’ the mutants 
We determined the kinetic constants from hydrolysis rates 
measured on four polypeptide amide substrates that were dif- 
ferent at the Pl position (Table lA,B). 
138 160 172 190 200 210 220 230 240 
I I I I I I I I I 
<---> <--> <--> <--> <--> 
Rat chymotz-yp. t 1 W -asg-vSSCMGDSggplvcqkdgvwtlagiVSWGSGVC-ststpAVYsrvtalmpwvqgileat 
mut .12 . fle.gkD..Q....................... .Y.-.alpdn..................... 
mut. 13 i fle.gkD..Q........................Y.-.alpdn..................... 
mut.43 i a Y fle.gkD..Q...................... ..Y.-.alpdn..................... 
mut. 19 . . fle.gkD..Q........................Y.-.alp....................... 
mut.21 i fle.gkD..Q........................Y.-.alp....................... 
mut.49 i a Y fle.gkD..Q........................Y.-.alp....................... 
Rat trap. II i a Y fleggkDSCQGDSggpvvc--nge--lqgiVSWGYG-CalpdnpGWtkvcnyvdwiqdtiaan 
<---> <--<>-> <--> -__-____________ 
I I I I I I I I I 
138 160 172 190 200 210 220 230 240 
Fig. 1. The aligned amino acid sequences and the position of secondary structure elements around the Sl specificity site of wild-type chymotrypsin, 
trypsin and chymotrypsin mutants. The amino acids in loop1 (sites 185(a) through 198) and loop2 (sites 217 through 224) are in bold. (The loop 
assignments are different from those by Hedstrom et al. [2] Here they are defined as structures between the helices and sheet segments.) The amino 
acids that form the specificity pocket are in capital letters. These amino acids have at least one atom that is not further from the substrate than 
5 A. The position of the secondary structure elements is as determined by the hydrogen bonds in the bovine enzymes [19-211. Sheet segment: _; 
helix: ====; b-turn <-->. 
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Fig. 2. H-bonding interaction possibilities between loops 1 and 2 in bovine trypsin (A) and bovine chymotrypsin (B). (A) the structure of free trypsin 
(Brookhaven Protein Data Bank identification number 1TPO) and a trypsin-pancreatic trypsin inhibitor complex (2PTC [7]) were aligned. Only the 
lysine side chain of the inhibitor (yellow) is shown from the trypsin-inhibitor complex. (B) the structure of free a-chymotrypsin (4CHA [22]) and 
the N-acetyl-L-phenylalanyl-trifluormethyl ketone complexed a-chymotrypsin (6CHA [23]) were aligned. Only the Pl-Phe residue is shown from the 
latter (magenta). Besides the C, Ca and N atoms in the main chain and the Cys191-Cys220 disulphide bridge, only those residues and atoms are 
displayed that can take part in hydrogen bonds. (Residues 196198 in loop1 are omitted.) The structure is orange where the main chain atom positions 
are different in trypsin and chymotrypsin. Dotted lines are the hydrogen bonds. 
The introduction of trypsin specific aspartate residue at the 
bottom of the substrate binding pocket (site 189) reduced the 
activity on chymotrypsin substrates (Phe or Tyr at the Pl site) 
by three orders of magnitude but did not change the intrinsic 
tryptic activity of chymotrypsin on lysyl substrates. The fall in 
chymotryptic activity was entirely due to a decrease in the 
catalytic rate constant. Though the Serl89Asp mutation re- 
duced the specificity, the enzyme remained basically chymo- 
trypsin-like (Table 1). 
The further substitutions in mutants 12, 13, 19, 21, 43 and 
49 reduced the chymotryptic activity by 14 orders of magni- 
tude relative to Asp 189 chymotrypsin as a result of decrease in 
catalytic rate constants and of elevation in K,,, values (Table 
lA,B). Again, the activity of most of these mutants on lysyl 
substrate remained essentially the same as that of wild type 
chymotrypsin. However, on arginyl substrate the activities of 
mutants 24 and 49 dropped even below that of wild-type chy- 
motrypsin due to fall in kc,, values. Despite the numerous differ- 
ences in the amino acid replacements among chymotrypsin 
mutants 12, 13, 19, 21, 43 and 49, their catalytic properties on 
Phe, Tyr and Lys substrates were not significantly different, 
and they were essentially non-specific enzymes (Table 1B). 
4. Discussion 
The kinetic data of our chymotrypsin mutants show that the 
trypsin + chymotrypsin and chymotrypsin + trypsin specific- 
ity conversions are not ‘symmetric’ cases despite the almost 
identical architectures of the two proteins: reverse substitutions 
in chymotrypsin at sites that were sufficient to be mutated to 
change the specificity of trypsin, yielded only non-specific en- 
zymes of very low activity. This failure of specificity conversion 
was unexpected, and indicates that the sites influencing the 
specificity must be at least partially different in trypsin and 
chymotrypsin. 
Trypsin and chymotrypsin take part by main chain atoms in 
the interaction with the Pl substrate residue, therefore, through 
side chain interactions, numerous amino acids can indirectly 
influence the substrate binding by cooperatively determining 
the position of atoms that interact with the substrate. All these 
interactions are part of a hydrogen bonding network intertwin- 
ing loop1 and 100~2. These contain different number of bonds, 
and have a dissimilar arrangement in the two enzymes at sites 
where the loops are divergent (Figs. 1 and 2). The trypsin and 
chymotrypsin type stabilization of this hydrogen bonding net- 
146 I. Venekei et al. IFEBS Letters 379 (1996) 143-147 
Table 1A 
Kinetic constants determined on chymotrypsin (A) polypeptide amide substrates, Succinyl-AlaAlaProXaa- 
Enzyme Xaa = Phe Xaa = Tyr 
k CM 
7.1 x lo3 
1.1 x loo 
3.5 x loo 
6.6 x 1o-2 
ND 
4.1 x 10-Z 
5.8 x 10-l 
2.5 x lo-’ 
4.7 x loo 
wild-type chymotrypsin 
S189D 
mut. 12 
mut. 13 
mut. 43 
mut. 19 
mut. 21 
mut. 49 
wild-type trypsin 
[k,J = s-‘; [K,,J = PM; 
k cat 
5.2 x lo3 
6.2 x 10’ 
2.3 x 10” 
5.0 x 1o-2 
9.6 x 10-l 
2.6 x lo-’ 
2.8 x 10-l 
2.2 x 10-l 
6.2 x 10’ 
K, 
2.3 x 10’ 
4.1 x 10’ 
8.9 x 10’ 
9.7 x IO’ 
2.4 x lo* 
3.8 x 10’ 
3.4 x lo* 
6.8 x lo* 
1.3 x lo* 
ka,K 
2.3 x lo* 
1.5 x 10-l 
2.5 x lo-2 
5.2 x lO-4 
4.0 x lo-3 
6.8 x lo-5 
8.2 x lo-“ 
3.2 x lO-4 
4.8 x lo-* 
K, k,,,lK, 
1.1 x 10’ 6.5 x lo2 
4.0 x 10’ 2.8 x lO-2 
1.7 x lo* 2.0 x 1o-2 
9.2 x 10’ 7.1 x lo-4 
ND ND 
2.4 x 10’ 1.7 x 1o-4 
3.4 x lo* 1.7 x lo--’ 
2.3 x lo* 1.0 x 1o-3 
1.5 x lo2 3.1 x lo-2 
[k,JK”J = s-’ .pM-‘. 
Table 1B 
Kinetic constants determined on trypsin (B) polypeptide amide substrates, Succinyl-AlaAlaProXaa-AMC 
Enzyme Xaa = Lys Xaa = Arg 
k cat K, k,,JK, kc,, K, k,,JK, 
specificity* 
wild-type chymotrypsin 
S189D 
mut. 12 
mut. 13 
mut. 43 
mut. 19 
mut. 21 
mut. 49 
wild-type trypsin 
[&,,I = s-‘; [K,,] = PM; 
1.1 x 100 3.5 x 102 3.1 x 10-j 7.2 x 10’ 
3.4 x 10-l 1.7 x lo2 2.0 x lo-’ 1.1 x 10-l 
ND ND ND 7.5 x 10’ 
4.6 x lo-’ 3.0 x lo2 1.5 x 10-l 1.6 x 10’ 
4.8 x 10’ 4.2 x lo2 1.1 x 1o-2 ND 
6.9 x 10-l 1.3 x lo2 5.3 x lo-3 6.5 x lO-2 
4.0 x 10-l 1.5 x 102 2.7 x lO-3 5.8 x lo-* 
2.2 x 10-l 1.2 x 102 1.8 x 1O-3 6.4 x lo-* 
4.2 x IO3 3.2 x 10’ 1.3 x lo3 1.1 x lo4 
[k,,,lKJ = s& .pM-‘; *specificity = [k,,,/Km]phd[k,,,lK,]~~s. 
1.1 x lo2 
8.6 x 10’ 
1.1 x lo3 
7.9 x lo* 
ND 
3.0 x 10’ 
1.4 x lo2 
8.0 x 10’ 
1.3 x lo0 
6.9 x 1O-2 7.4 x lo4 
1.3 x lo-3 7.5 x 10’ 
6.8 x lo-2 2.1 x 10’ 
7.8 x lo-* 3.5 x 10-l 
ND 3.6 x 10’ 
2.2 x 1o-3 1.3 x 10-l 
4.1 x 1o-4 3.0 x loo 
8.0 x lO-4 1.8 x 10’ 
8.4 x 10’ 3.7 x lo-5 
work defines the structure of the specificity determinant sites 
(e.g. 189 and 216 in trypsin [l l]), gives a distinct structure to 
the water molecules located in the specificity pockets and prob- 
ably lends to the substrate binding sites a dissimilar deformabil- 
ity [24]. It has been proposed that different conformational 
flexibilities rather than evident differences in the tertiary struc- 
tures of the specificity sites of trypsin and chymotrypsin may 
represent the true structural basis for substrate discrimination 
[24,25]. 
The poor activity and the non-specific character of our chy- 
motrypsin mutants might be the consequence of a missing 
network stabilization, i.e. of a (partial) disorder in the H- 
bonding of the two loops, similarly to the case of 
Tr + Cy[Sl + Ll + L2] trypsin mutant [ 11,14]. Concerning the 
origin of disorder we suppose, that the modified, trypsin-like 
loops cannot pack well in the chymotrypsin scaffold. Further 
studies are needed to eliminate the possible structural incom- 
patibiliti(es) between the loops and the other parts of the pro- 
tein, and to reveal additional site(s) that are involved in the 
substrate discrimination of trypsin and chymotrypsin. 
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